My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 111

    1.

    The common hyperlipoproteinemias: an understanding of disease mechanisms and their control.

    Fisher WR, Truitt DH.

    Ann Intern Med. 1976 Oct;85(4):497-508. Review.PMID: 184730 [PubMed - indexed for MEDLINE]Related articles

    2.

    Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.

    Vessby B, Lithell H, Gustafsson IB, Borberg J.

    Atherosclerosis. 1979 Aug;33(4):457-77.PMID: 228684 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V]

    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.

    Arzneimittelforschung. 1983;33(5):776-9. German. PMID: 6683558 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.

    Patsch JR, Yeshurun D, Jackson RL, Gotto AM Jr.

    Am J Med. 1977 Dec;63(6):1001-9. No abstract available. PMID: 204188 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pathophysiology of lipoprotein transport.

    Brunzell JD, Chait A, Bierman EL.

    Metabolism. 1978 Sep;27(9):1109-27. Review.PMID: 210352 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)]

    Weisweiler P, Schwandt P.

    Klin Wochenschr. 1977 Aug 15;55(16):791-4. German. PMID: 198601 [PubMed - indexed for MEDLINE]Related articles

    7.

    Dietary and drug treatment of primary hyperlipoproteinemia.

    [No authors listed]

    Ann Intern Med. 1972 Aug;77(2):267-94. Review. No abstract available. PMID: 4345081 [PubMed - indexed for MEDLINE]Related articles

    8.

    Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.

    Orö L, Olsson AG, Rössner S, Carlson LA.

    Postgrad Med J. 1975;51(8):suppl 76-81.PMID: 215986 [PubMed - indexed for MEDLINE]Related articles

    9.

    Should hyperlipoproteinemia be treated in patients with coronary artery disease?

    Rider AK.

    JAMA. 1975 Jul 21;233(3):275-7. No abstract available. PMID: 168412 [PubMed - indexed for MEDLINE]Related articles

    10.

    Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.

    Oki JC.

    Pharmacotherapy. 1995 May-Jun;15(3):317-37. Review.PMID: 7667166 [PubMed - indexed for MEDLINE]Related articles

    11.

    Acute effect of dietary therapy of type IV hyperlipoproteinaemia on the serum and lipoprotein concentrations and relative composition.

    Ballantyne D, Olsson AG, Carlson LA.

    Atherosclerosis. 1978 May;30(1):79-87.PMID: 209798 [PubMed - indexed for MEDLINE]Related articles

    12.

    Bile acid metabolism in hyperlipoproteinaemia.

    Hellström K, Einarsson K.

    Clin Gastroenterol. 1977 Jan;6(1):103-28. Review. No abstract available. PMID: 196796 [PubMed - indexed for MEDLINE]Related articles

    13.

    The beta-lipoprotein doublet in type 3 hyperlipoproteinemia.

    Papadopoulos NK, Herbert PN.

    Clin Chem. 1977 Jun;23(6):978-81.PMID: 192490 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Xanthomatosis and hyperlipoproteinemia; a review.

    Polano MK.

    Dermatologica. 1974;149(1):1-9. No abstract available. PMID: 4372111 [PubMed - indexed for MEDLINE]Related articles

    15.

    Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.

    Falko JM, Witztum JL, Schonfeld G, Weidman SW, Kolar JB.

    Am J Med. 1979 Feb;66(2):303-10. No abstract available. PMID: 218451 [PubMed - indexed for MEDLINE]Related articles

    16.

    Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-beta-disease) a cause or an effect of increased apolipoprotein E levels?

    Ganesan D, Bass HB, McConathy WJ, Alaupovic P.

    Metabolism. 1976 Nov;25(11):1189-95.PMID: 185483 [PubMed - indexed for MEDLINE]Related articles

    17.

    Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia.

    Miettinen TA, Penttilä IM, Lampainen E.

    Acta Med Scand. 1972 Sep;192(3):177-82. No abstract available. PMID: 4341290 [PubMed - indexed for MEDLINE]Related articles

    18.

    Treatment of common lipoprotein disorders.

    Brown WV, Goldberg IJ, Ginsberg HN.

    Prog Cardiovasc Dis. 1984 Jul-Aug;27(1):1-20. Review.PMID: 6330792 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Classification of hyperlipoproteinemias]

    Zabel R.

    Dermatol Monatsschr. 1974 Feb;160(2):134-50. German. No abstract available. PMID: 4369507 [PubMed - indexed for MEDLINE]Related articles

    20.

    Combined hyperlipoproteinemia. Evidence for a new lipoprotein phenotype.

    Rose HG, Kranz P, Weinstock M, Juliano J, Haft JI.

    Atherosclerosis. 1974 Jul-Aug;20(1):51-64. No abstract available. PMID: 4376406 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity